1552280-87-1Relevant academic research and scientific papers
Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors
Huang, Daowei,Yang, Jixia,Zhang, Qingwei,Wang, Guan,Zhang, Zixue,Zhang, Yue,Li, Jianqi
, (2021/06/30)
The HGF/Met signaling pathway is over-expressed in many types of cancers and closely related to oncogenesis and metastasis. Thus, we developed novel N-phenylpyrimidin-2-amine derivatives to test their inhibitory activities towards c-Met kinase, and most o
Substituted arylamino aromatic heterocyclic compounds and application thereof as anti-tumor drugs
-
Paragraph 0147; 0148; 0149; 0150, (2017/10/31)
The invention discloses substituted arylamino aromatic heterocyclic compounds as shown in a formula (I), pharmacologically acceptable salts of the compounds, a preparation method of the compounds, and use of the compounds in preparation of anti-tumor drug
SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE
-
, (2015/02/19)
The present invention provides novel substituted pyrazolone compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE
-
, (2014/02/16)
The present invention provides novel substituted pyrazolone compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
